H49.81 Kearns-Sayre syndrome

Name of the Condition

• Kearns-Sayre syndrome

Summary

Kearns-Sayre syndrome is a rare mitochondrial disorder characterized by progressive external ophthalmoplegia (weakness of the eye muscles), pigmentary retinopathy, and cardiac conduction defects. It typically presents before age 20 and may involve other systemic manifestations such as ataxia, hearing loss, or endocrine abnormalities. The condition is caused by deletions in mitochondrial DNA and follows a progressive course.

Causes

Kearns-Sayre syndrome is caused by large deletions in mitochondrial DNA, which disrupt energy production in cells. These deletions are usually sporadic and not inherited from parents. The exact trigger for these deletions is not fully understood, but they result in impaired mitochondrial function affecting multiple organ systems.

Risk Factors

• Age of onset (typically before 20 years)
• Sporadic mitochondrial DNA deletions
• Family history of mitochondrial disorders (rare)

Symptoms

• Progressive external ophthalmoplegia (eye muscle weakness)
• Pigmentary retinopathy (retinal changes)
• Cardiac conduction defects (e.g., heart block)
• Ataxia (loss of coordination)
• Hearing loss
• Endocrine abnormalities (e.g., diabetes, thyroid issues)
• Short stature
• Cognitive impairment (in some cases)

Diagnosis

Diagnosis is based on clinical features (ophthalmoplegia, retinopathy, cardiac conduction defects) and confirmed by genetic testing showing mitochondrial DNA deletions. Additional tests may include electrocardiography (ECG) for cardiac conduction, brain MRI for structural changes, and blood tests for metabolic or endocrine abnormalities. Muscle biopsy may reveal ragged-red fibers, though this is less commonly performed now with genetic testing.

Treatment Options

Treatment is supportive and focuses on managing symptoms. This may include cardiac pacing for conduction defects, hormone replacement for endocrine issues, physical therapy for ataxia, and hearing aids for hearing loss. Regular monitoring of cardiac and metabolic function is essential. No cure exists, but interventions can improve quality of life.

Prognosis and Follow-Up

Prognosis varies, with cardiac complications being a major concern. Lifespan may be reduced due to arrhythmias or other systemic issues. Regular follow-up with cardiologists, neurologists, and endocrinologists is critical to manage complications. Early detection and intervention for cardiac or metabolic problems can improve outcomes.

Complications

• Complete heart block (requiring pacemaker)
• Respiratory failure
• Diabetes or other endocrine disorders
• Progressive muscle weakness
• Vision or hearing loss
• Cognitive decline

Lifestyle & Prevention

No specific prevention exists due to its genetic basis. Patients should avoid medications that may worsen mitochondrial function (e.g., certain anesthetics). Regular exercise, a balanced diet, and avoiding smoking may support overall health. Genetic counseling is recommended for families.

When to Seek Professional Help

Seek immediate care for symptoms like fainting, chest pain, or shortness of breath (possible cardiac issues). Regular check-ups are needed for monitoring cardiac, endocrine, and neurological status. Any new or worsening symptoms (e.g., vision changes, weakness) should prompt evaluation.

Tips for Medical Coders

Document the presence of key features (ophthalmoplegia, retinopathy, cardiac conduction defects) to support the diagnosis. Note any associated conditions (e.g., diabetes, ataxia) as they may require additional coding. Ensure genetic confirmation is documented if available, as it strengthens the clinical basis for the code.